The evaluation of the immunomodulating properties of ERA-63 a pharmaceutical with estrogenic activity

This paper describes studies performed with ERA-63 a low molecular weight pharmaceutical with intended immunomodulatory effects. Since this compound was also known to have estrogenic activity a non-conventional approach was taken in order to differentiate between estrogenic and non-estrogenic-induced immunomodulatory effects. EE was included not...

Hemolytische ziekte van de pasgeborene en irregulaire- bloedgroepantagonisme in Nederland: Prevalentie en morbiditeit [Haemolytic disease of the newborn and irregular blood group antagonism in the Netherlands: Prevalence and morbidity]

Objective. To inventory prevalence and morbidity of haemolytic disease of newborn caused by irregular anti-erythrocyte antibodies other than antirhesus-D. Design. Prospective registration study. Method. All paediatricians (n = 380) in general hospitals and contact persons (n = 79) in university hospitals were asked for monthly reports of...